[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-cats":3,"header_nav":4,"site_settings":50,"footer-nav":200,"articles-2nwz9crm5ev554p":218,"news-related-2nwz9crm5ev554p":234},[],[5,14,20,26,32,38,44],{"collectionId":6,"collectionName":7,"id":8,"label":9,"label_en":10,"position":11,"sort":12,"to":13},"pbc_3079337391","navigation","8hvz111cztwtf6i","关于我们","About Us","header",1,"\u002Fabout",{"collectionId":6,"collectionName":7,"id":15,"label":16,"label_en":17,"position":11,"sort":18,"to":19},"9d57585v6wd81ob","硅基芯片","Silicon-Based Biochips",2,"\u002Fchip",{"collectionId":6,"collectionName":7,"id":21,"label":22,"label_en":23,"position":11,"sort":24,"to":25},"mq9ap452ye9u2h1","人工智能","Artificial Intelligence",3,"\u002Fai",{"collectionId":6,"collectionName":7,"id":27,"label":28,"label_en":29,"position":11,"sort":30,"to":31},"384105938294iqe","业务合作","Business Partnerships",4,"\u002Fbusiness",{"collectionId":6,"collectionName":7,"id":33,"label":34,"label_en":35,"position":11,"sort":36,"to":37},"gurwh855qx5x6z4","新闻洞察","News",5,"\u002Fnews",{"collectionId":6,"collectionName":7,"id":39,"label":40,"label_en":41,"position":11,"sort":42,"to":43},"55ii5pqdkj1kdm3","加入我们","Join Us",6,"\u002Fjoin",{"collectionId":6,"collectionName":7,"id":45,"label":46,"label_en":47,"position":11,"sort":48,"to":49},"xn76c1083o2wu6o","联系我们","Contact Us",7,"\u002Fcontact",[51,58,62,66,71,76,81,86,90,94,99,104,109,113,117,121,126,130,135,140,145,150,155,160,164,169,174,179,183,187,191,195],{"collectionId":52,"collectionName":53,"id":54,"key":55,"rich":56,"rich_en":56,"value":57,"value_en":57},"pbc_3940974","site_settings","d6b65u865t21sv6","contact_phone_400","","400 025 2565",{"collectionId":52,"collectionName":53,"id":59,"key":60,"rich":56,"rich_en":56,"value":61,"value_en":61},"t63em90l5t0057n","contact_phone_office","+86 755-3360 5888（0755-3360 5888）",{"collectionId":52,"collectionName":53,"id":63,"key":64,"rich":56,"rich_en":56,"value":65,"value_en":56},"iq8p641sog8x9l1","contact_hours","9:00-18:00",{"collectionId":52,"collectionName":53,"id":67,"key":68,"rich":56,"rich_en":56,"value":69,"value_en":70},"96j6s7t0fp409nl","contact_address_1","珠海市横琴粤澳深度合作区","Hengqin Guangdong-Macao In-Depth Cooperation Zone, Zhuhai, China",{"collectionId":52,"collectionName":53,"id":72,"key":73,"rich":56,"rich_en":56,"value":74,"value_en":75},"r6i9s5b90ymlf8x","contact_address_2","深圳市南山区、龙华区","Nanshan & Longhua Districts, Shenzhen, China",{"collectionId":52,"collectionName":53,"id":77,"key":78,"rich":56,"rich_en":56,"value":79,"value_en":80},"f4c7i35vq97ewp2","contact_address_3","广州市黄埔区","Huangpu District, Guangzhou, China",{"collectionId":52,"collectionName":53,"id":82,"key":83,"rich":56,"rich_en":56,"value":84,"value_en":85},"ko6t44bi839hodo","about_intro_body","iCarbonX由王俊博士于2015年创立，总部位于中国深圳。\r\n\r\n一家开创性的数字生命“独角兽”企业，利用人工智能和基于硅的生物芯片技术开展全球药物研发与精准诊断，推动基因组学、蛋白质组学及数字健康行业的创新发展。\r\n\r\n其核心使命是将“数字生活”确立为推动下一代医疗健康技术发展的核心引擎。","Founded by Dr. Jun Wang in 2015 and headquartered in Shenzhen, China, iCarbonX is a pioneering Digital Life unicorn company.\r\n\r\nLeveraging artificial intelligence and silicon-based biochip technologies, iCarbonX is advancing global drug discovery and precision diagnostics, driving innovation across genomics, proteomics, and digital health.\r\n\r\nThe company’s mission is to establish Digital Life as a core engine for the next generation of healthcare technologies, enabling a new paradigm for understanding, predicting, and managing human health.",{"collectionId":52,"collectionName":53,"id":87,"key":88,"rich":56,"rich_en":56,"value":89,"value_en":56},"7mzu6m751f2gi9s","footer_qr_wechat","\u002Fimages\u002Fqr-wechat.png",{"collectionId":52,"collectionName":53,"id":91,"key":92,"rich":56,"rich_en":56,"value":93,"value_en":56},"0mj7k314c63r901","footer_qr_service","\u002Fimages\u002Fqr-service.png",{"collectionId":52,"collectionName":53,"id":95,"key":96,"rich":56,"rich_en":56,"value":97,"value_en":98},"17s4u72w2r5xx61","footer_copyright","碳云智能 版权所有","2026 iCarbonX. All Rights Reserved.",{"collectionId":52,"collectionName":53,"id":100,"key":101,"rich":56,"rich_en":56,"value":102,"value_en":103},"1r73785526oyb5g","footer_icp","粤ICP备15107268号","Guangdong ICP 15107268",{"collectionId":52,"collectionName":53,"id":105,"key":106,"rich":56,"rich_en":56,"value":107,"value_en":108},"m18017xwyg619nz","footer_bottom_links","免责声明|隐私政策|合作留言","Legal Notice | Privacy Policy | Partnership Inquiry",{"collectionId":52,"collectionName":53,"id":110,"key":111,"rich":56,"rich_en":56,"value":112,"value_en":56},"dacxba346f9gbkb","company_name","碳云智能",{"collectionId":52,"collectionName":53,"id":114,"key":115,"rich":56,"rich_en":56,"value":116,"value_en":56},"f56760493weie55","company_name_en","iCarbonX",{"collectionId":52,"collectionName":53,"id":118,"key":119,"rich":56,"rich_en":56,"value":120,"value_en":56},"8rb3vp7rrvmk47x","contact_map_image","\u002Fimages\u002Fcontact-map.jpg",{"collectionId":52,"collectionName":53,"id":122,"key":123,"rich":56,"rich_en":56,"value":124,"value_en":125},"9l39447nvqg0h82","home_hero_title","碳云生命科学","iCarbonX Life Sciences",{"collectionId":52,"collectionName":53,"id":127,"key":128,"rich":56,"rich_en":56,"value":129,"value_en":10},"8z84pp8eh36l23i","about_intro_title","公司简介",{"collectionId":52,"collectionName":53,"id":131,"key":132,"rich":56,"rich_en":56,"value":133,"value_en":134},"7p72xq4e1hz3x70","breadcrumb_home","首页","Home",{"collectionId":52,"collectionName":53,"id":136,"key":137,"rich":56,"rich_en":56,"value":138,"value_en":139},"5i7p416ohiwsi20","contact_hero_subtitle","让科技创新驱动生命科学与医疗健康的发展","Advancing Life Sciences and Healthcare Through Scientific Innovation.",{"collectionId":52,"collectionName":53,"id":141,"key":142,"rich":56,"rich_en":56,"value":143,"value_en":144},"y42721r8l05o24e","contact_section_info_title","联系方式","Contact Information",{"collectionId":52,"collectionName":53,"id":146,"key":147,"rich":56,"rich_en":56,"value":148,"value_en":149},"w2k2150u9rfvgs9","contact_section_form_title","合作留言","Partnership Inquiry",{"collectionId":52,"collectionName":53,"id":151,"key":152,"rich":56,"rich_en":56,"value":153,"value_en":154},"547lm3f26e80hrk","contact_label_phone","联系电话：","Phone",{"collectionId":52,"collectionName":53,"id":156,"key":157,"rich":56,"rich_en":56,"value":158,"value_en":159},"pv1j69xs0p60178","contact_label_address","公司地址：","Address",{"collectionId":52,"collectionName":53,"id":161,"key":162,"rich":56,"rich_en":56,"value":163,"value_en":47},"6f6u830ngs8ad17","contact_seo_title","联系我们 — 碳云智能",{"collectionId":52,"collectionName":53,"id":165,"key":166,"rich":56,"rich_en":56,"value":167,"value_en":168},"op5n44iu558vm23","contact_seo_description","联系碳云智能，获取更多产品与服务信息。","Contact iCarbonX to learn more about our products and services.",{"collectionId":52,"collectionName":53,"id":170,"key":171,"rich":172,"rich_en":173,"value":56,"value_en":56},"20walg0187po22p","disclaimer","\u003Cp>法律声明\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>感谢您访问本公司网站（以下简称“本网站”）。为保障您与本公司的权益，请在使用本网站前仔细阅读以下法律声明。当您进入或使用本网站，即视为您已阅读、理解并同意遵守本声明的内容及所有相关适用法律。如您不同意以下任何条款，请立即停止使用本网站。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>一、知识产权\u003C\u002Fp>\r\n\u003Cp>本网站所载全部内容，包括但不限于文字、图片、音视频、图像、声音、文件、设计、版式及网站架构，均受《中华人民共和国著作权法》《中华人民共和国商标法》及其他相关知识产权法律保护。除法律另有规定或经本公司事先书面授权外，任何人不得以任何形式（包括但不限于复制、改编、编辑、传播、公开传输、展示或其他使用方式）使用本网站内容。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>二、免责声明\u003C\u002Fp>\r\n\u003Cp>本网站所提供的信息仅供参考。本公司不对信息的准确性、及时性、完整性或适用性作出任何明示或默示保证，并保留随时修改、更新或删除网站内容的权利。\u003C\u002Fp>\r\n\u003Cp>使用者因浏览、使用或引用本网站内容而造成的任何损害（包括直接、间接、附带或衍生损失），本公司概不承担任何责任。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>三、第三方链接\u003C\u002Fp>\r\n\u003Cp>为方便网络用户，本网站可能提供指向第三方网站的链接。使用者对相关网站内容的使用应自行评估并承担风险，本公司不对其内容的准确性、合法性、安全性或因使用产生的任何损害承担责任。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>四、使用限制\u003C\u002Fp>\r\n\u003Cp>使用者不得以任何方式从事以下行为：\u003C\u002Fp>\r\n\u003Cp>未经授权擅自进入本网站的服务器、系统或相关设备；\u003C\u002Fp>\r\n\u003Cp>散布病毒、恶意程序或从事其他危害网站安全的行为；\u003C\u002Fp>\r\n\u003Cp>以任何可能损害本公司合法权益或影响网站正常运营的方式使用本网站；\u003C\u002Fp>\r\n\u003Cp>恶意篡改或歪曲本网站提供的资料与素材，若因此导致与原始内容不符并造成损害，使用者须自行承担相应的民事或刑事法律责任；\u003C\u002Fp>\r\n\u003Cp>本声明不赋予使用者代表本网站发表意见、建议或视为本公司对相关衍生内容予以认可。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>五、隐私政策\u003C\u002Fp>\r\n\u003Cp>本公司高度重视您的个人信息保护。当您使用本网站或提供个人信息时，我们将依据《中华人民共和国个人信息保护法》及本公司《隐私政策》进行处理与保护。建议您详细阅读本网站所载隐私政策，以了解我们收集、使用、存储及保护个人信息的方式。若您不同意本政策，请勿向本公司提供任何个人信息。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>六、适用法律与管辖\u003C\u002Fp>\r\n\u003Cp>本法律声明的解释与适用，以及因使用本网站所引起的争议，均适用中华人民共和国法律，并由本公司所在地人民法院管辖。\u003C\u002Fp>","\u003Ch1 data-section-id=\"sq8q4f\" data-start=\"0\" data-end=\"14\">Legal Notice\u003C\u002Fh1>\r\n\u003Cp data-start=\"16\" data-end=\"519\">Thank you for visiting the official website of the Company (the \"Website\"). To protect both your interests and those of the Company, please read the following Legal Notice carefully before accessing or using this Website. By accessing or using this Website, you acknowledge that you have read, understood, and agreed to be bound by this Legal Notice and all applicable laws and regulations. If you do not agree with any part of this Legal Notice, please discontinue your use of this Website immediately.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"3a4rq9\" data-start=\"521\" data-end=\"548\">1. Intellectual Property\u003C\u002Fh2>\r\n\u003Cp data-start=\"550\" data-end=\"906\">All content available on this Website, including but not limited to text, images, graphics, audio, video, documents, designs, layouts, and the overall website structure, is protected by the Copyright Law of the People's Republic of China, the Trademark Law of the People's Republic of China, and other applicable intellectual property laws and regulations.\u003C\u002Fp>\r\n\u003Cp data-start=\"908\" data-end=\"1156\">Unless otherwise permitted by law or expressly authorized in writing by the Company, no person or organization may reproduce, modify, edit, distribute, publicly transmit, display, publish, or otherwise use any content from this Website in any form.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"ib2d2y\" data-start=\"1158\" data-end=\"1174\">2. Disclaimer\u003C\u002Fh2>\r\n\u003Cp data-start=\"1176\" data-end=\"1532\">The information provided on this Website is for general informational purposes only. The Company makes no express or implied warranties regarding the accuracy, timeliness, completeness, reliability, or suitability of any information contained on this Website and reserves the right to modify, update, or remove any content at any time without prior notice.\u003C\u002Fp>\r\n\u003Cp data-start=\"1534\" data-end=\"1744\">The Company shall not be liable for any direct, indirect, incidental, consequential, or other damages arising from or related to the access to, use of, or reliance upon the information provided on this Website.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"hmhkff\" data-start=\"1746\" data-end=\"1769\">3. Third-Party Links\u003C\u002Fh2>\r\n\u003Cp data-start=\"1771\" data-end=\"2106\">For your convenience, this Website may contain links to third-party websites. Your access to and use of such websites are entirely at your own risk. The Company assumes no responsibility for the accuracy, legality, security, privacy practices, or content of any third-party website, nor for any loss or damage resulting from their use.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"xb7ely\" data-start=\"2108\" data-end=\"2128\">4. Acceptable Use\u003C\u002Fh2>\r\n\u003Cp data-start=\"2130\" data-end=\"2188\">Users shall not engage in any of the following activities:\u003C\u002Fp>\r\n\u003Cul data-start=\"2190\" data-end=\"2959\">\r\n\u003Cli data-section-id=\"18rb8j\" data-start=\"2190\" data-end=\"2282\">Accessing the Website's servers, systems, or related infrastructure without authorization;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"1g0nz1c\" data-start=\"2283\" data-end=\"2412\">Transmitting viruses, malicious code, or engaging in any activity that may compromise the security or integrity of the Website;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"kgdrh2\" data-start=\"2413\" data-end=\"2556\">Using the Website in any manner that may infringe upon the Company's legitimate rights or interfere with the normal operation of the Website;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"dsi9py\" data-start=\"2557\" data-end=\"2752\">Altering, distorting, or misrepresenting any content or materials obtained from this Website. Users shall bear full civil or criminal liability for any consequences resulting from such actions;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"w4hxm1\" data-start=\"2753\" data-end=\"2959\">Representing themselves as speaking on behalf of the Website or the Company, or implying that the Company endorses any opinions, recommendations, or derivative content without prior written authorization.\u003C\u002Fli>\r\n\u003C\u002Ful>\r\n\u003Ch2 data-section-id=\"1ajrc9k\" data-start=\"2961\" data-end=\"2974\">5. Privacy\u003C\u002Fh2>\r\n\u003Cp data-start=\"2976\" data-end=\"3268\">The Company is committed to protecting your personal information. Any personal information collected through your use of this Website will be processed and protected in accordance with the Personal Information Protection Law of the People's Republic of China and the Company's Privacy Policy.\u003C\u002Fp>\r\n\u003Cp data-start=\"3270\" data-end=\"3520\">We encourage you to review our Privacy Policy to understand how we collect, use, store, and safeguard your personal information. If you do not agree with our Privacy Policy, please refrain from providing any personal information through this Website.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"38rmmm\" data-start=\"3522\" data-end=\"3558\">6. Governing Law and Jurisdiction\u003C\u002Fh2>\r\n\u003Cp data-start=\"3560\" data-end=\"3675\">This Legal Notice shall be governed by and construed in accordance with the laws of the People's Republic of China.\u003C\u002Fp>\r\n\u003Cp data-start=\"3677\" data-end=\"3866\" data-is-last-node=\"\" data-is-only-node=\"\">Any dispute arising out of or relating to the use of this Website or this Legal Notice shall be submitted to the competent People's Court with jurisdiction over the location of the Company.\u003C\u002Fp>",{"collectionId":52,"collectionName":53,"id":175,"key":176,"rich":177,"rich_en":178,"value":56,"value_en":56},"m6a3t8g6b8d22d6","privacy_policy","\u003Cp>隐私政策\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>为使您在使用本网站提供的各项服务与信息时更加安心，本公司特此说明本网站的隐私政策，旨在保障您的个人隐私权益。请您仔细阅读以下内容：\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>一、适用范围\u003C\u002Fp>\r\n\u003Cp>本网站为提供安全、可用与完整的信息服务，并符合相关法律法规的要求，制定本政策。以下政策适用于您在使用本网站所提供的各类服务及活动时，涉及的个人信息收集、处理、使用与保护之相关做法，但不适用于本网站所链接的其他网站。凡经由本网站链接进入的其他网站，适用各该网站的隐私政策，与本网站无关，本网站亦不承担任何相关责任。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>二、个人信息的收集、处理及使用方式\u003C\u002Fp>\r\n\u003Cp>当您访问本网站所涉及的个人信息，其收集、处理及使用将依照《中华人民共和国个人信息保护法》及本公司业务相关规定办理，以充分保障您的隐私权。但为向您提供更完善的个性化服务，本网站会记录使用者的 IP 地址、上网时间、Cookie 以及在网站内所浏览的页面等信息\u003Cspan style=\"font-family: 等线;\">，并仅对整体用户行为进行汇总分析，用于统计网站访问量、点击率等数据性评估，不涉及单个用户的身份识别。\u003C\u002Fspan>\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>三、信息保护\u003C\u002Fp>\r\n\u003Cp>本网站主机均配置有防火墙、防病毒系统等相关信息安全设备及必要的安全防护措施，以确保数据在传输过程中不被第三方非法获取。但请您理解，互联网并非绝对安全环境，本公司无法保证数据传输的绝对安全。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>四、外部网站链接\u003C\u002Fp>\r\n\u003Cp>本网站页面可能提供其他网站的链接，您可通过本网站进入其他网站。但该等网站不适用本网站的隐私政策，您须自行查阅并遵守该网站的隐私政策。本网站对第三方网站的内容或隐私政策不承担任何责任。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>五、信息提供的限制\u003C\u002Fp>\r\n\u003Cp>除下列情形外，本网站绝不会向第三方提供您的个人信息：\u003C\u002Fp>\r\n\u003Cp>配合司法机关合法调查；\u003C\u002Fp>\r\n\u003Cp>配合相关主管机关依职权需要的调查或使用；\u003C\u002Fp>\r\n\u003Cp>为维护及改进本网站服务，进行内部管理或业务运营所必需。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>六、设备信息的使用\u003C\u002Fp>\r\n\u003Cp>本网站会收集您使用的设备（如电脑、手机、平板电脑等）的信息，包括 Cookie 信息、移动设备信息、浏览器版本、操作系统类型，以及通过 Google Analytics 等网站分析工具所收集的相关信息。本网站可能识别您的设备，并基于您的使用情况为您提供个性化体验与内容。\u003C\u002Fp>\r\n\u003Cp>您也可以通过浏览器设置拒绝或限制部分数据收集。但请注意，如拒绝或禁用 Cookie，某些服务或功能可能无法正常使用。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>七、隐私政策的修订\u003C\u002Fp>\r\n\u003Cp>本网站将不时修订隐私与个人信息保护政策，并在政策有重大变更时，于网站上公布修订内容，以落实对您隐私权的保障。\u003C\u002Fp>\r\n\u003Cp> \u003C\u002Fp>\r\n\u003Cp>八、联系方式\u003C\u002Fp>\r\n\u003Cp>如您对本网站的隐私政策有任何疑问或建议，欢迎随时与我们联系，我们将竭诚为您提供帮助。\u003C\u002Fp>","\u003Ch1 data-section-id=\"1dp7kw\" data-start=\"0\" data-end=\"16\">Privacy Policy\u003C\u002Fh1>\r\n\u003Cp data-start=\"18\" data-end=\"230\">To help you use the services and information provided on this website with confidence, the Company hereby sets out this Privacy Policy to protect your personal privacy rights. Please read the following carefully.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"k18ylf\" data-start=\"232\" data-end=\"258\">1. Scope of Application\u003C\u002Fh2>\r\n\u003Cp data-start=\"260\" data-end=\"434\">This Policy has been formulated to ensure that this website provides secure, accessible, and complete information services in compliance with applicable laws and regulations.\u003C\u002Fp>\r\n\u003Cp data-start=\"436\" data-end=\"885\">It applies to the collection, processing, use, and protection of personal information in connection with the services and activities provided through this website. It does not apply to third-party websites linked from this website. Any third-party website accessed through such links is governed by its own privacy policy. This website assumes no responsibility for the content, privacy practices, or related activities of such third-party websites.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"1dnm8hd\" data-start=\"887\" data-end=\"948\">2. Collection, Processing, and Use of Personal Information\u003C\u002Fh2>\r\n\u003Cp data-start=\"950\" data-end=\"1266\">Any collection, processing, and use of personal information arising from your access to this website will be conducted in accordance with the Personal Information Protection Law of the People’s Republic of China and the Company’s relevant internal policies, with due regard for the protection of your privacy rights.\u003C\u002Fp>\r\n\u003Cp data-start=\"1268\" data-end=\"1648\">To provide more complete and personalized services, this website may record information such as your IP address, access time, cookies, and the pages you visit. Such information will only be used in aggregated form to analyze overall user behavior, including website traffic, click-through rates, and other statistical indicators, and will not be used to identify individual users.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"1twmmv6\" data-start=\"1650\" data-end=\"1676\">3. Information Security\u003C\u002Fh2>\r\n\u003Cp data-start=\"1678\" data-end=\"1909\">The servers used by this website are protected by firewalls, antivirus systems, and other necessary information security equipment and safeguards designed to help prevent unauthorized third-party access to data during transmission.\u003C\u002Fp>\r\n\u003Cp data-start=\"1911\" data-end=\"2088\">However, please understand that the internet is not an entirely secure environment, and the Company cannot guarantee the absolute security of data transmitted over the internet.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"68ks82\" data-start=\"2090\" data-end=\"2122\">4. Links to External Websites\u003C\u002Fh2>\r\n\u003Cp data-start=\"2124\" data-end=\"2400\">This website may contain links to other websites. You may access such websites through links provided on this website. However, those websites are not governed by this Privacy Policy. You should review and comply with the privacy policies of the relevant third-party websites.\u003C\u002Fp>\r\n\u003Cp data-start=\"2402\" data-end=\"2505\">This website assumes no responsibility for the content or privacy practices of any third-party website.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"13d5n8r\" data-start=\"2507\" data-end=\"2558\">5. Restrictions on the Disclosure of Information\u003C\u002Fh2>\r\n\u003Cp data-start=\"2560\" data-end=\"2675\">Except in the following circumstances, this website will not disclose your personal information to any third party:\u003C\u002Fp>\r\n\u003Cul data-start=\"2677\" data-end=\"3014\">\r\n\u003Cli data-section-id=\"zrxmtw\" data-start=\"2677\" data-end=\"2753\">To cooperate with lawful investigations conducted by judicial authorities;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"jdzy49\" data-start=\"2754\" data-end=\"2884\">To cooperate with investigations or requests made by competent regulatory authorities in accordance with their statutory powers;\u003C\u002Fli>\r\n\u003Cli data-section-id=\"1yqscld\" data-start=\"2885\" data-end=\"3014\">Where necessary for the internal management, business operations, maintenance, or improvement of this website and its services.\u003C\u002Fli>\r\n\u003C\u002Ful>\r\n\u003Ch2 data-section-id=\"1952gv7\" data-start=\"3016\" data-end=\"3047\">6. Use of Device Information\u003C\u002Fh2>\r\n\u003Cp data-start=\"3049\" data-end=\"3354\">This website may collect information about the devices you use, including computers, mobile phones, and tablets. Such information may include cookie data, mobile device information, browser version, operating system type, and information collected through website analytics tools such as Google Analytics.\u003C\u002Fp>\r\n\u003Cp data-start=\"3356\" data-end=\"3519\">This website may recognize your device and use information about your interactions with the website to provide a more personalized experience and relevant content.\u003C\u002Fp>\r\n\u003Cp data-start=\"3521\" data-end=\"3733\">You may refuse or limit certain types of data collection through your browser settings. However, please note that disabling or rejecting cookies may prevent certain services or features from functioning properly.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"1vl95v6\" data-start=\"3735\" data-end=\"3771\">7. Changes to this Privacy Policy\u003C\u002Fh2>\r\n\u003Cp data-start=\"3773\" data-end=\"4036\">This website may revise this Privacy Policy and its personal information protection practices from time to time. Where material changes are made, the revised content will be published on this website to help ensure the continued protection of your privacy rights.\u003C\u002Fp>\r\n\u003Ch2 data-section-id=\"1cga21h\" data-start=\"4038\" data-end=\"4054\">8. Contact Us\u003C\u002Fh2>\r\n\u003Cp data-start=\"4056\" data-end=\"4197\" data-is-last-node=\"\" data-is-only-node=\"\">Should you have any questions or suggestions regarding this Privacy Policy, please feel free to contact us. We will be pleased to assist you.\u003C\u002Fp>",{"collectionId":52,"collectionName":53,"id":180,"key":181,"rich":56,"rich_en":56,"value":182,"value_en":182},"8g9a375qs0t69q6","contact_phone_3","+86 756-8858 456（0756-8858 456）",{"collectionId":52,"collectionName":53,"id":184,"key":185,"rich":56,"rich_en":56,"value":186,"value_en":186},"zvlv3z66ffi1fn2","contact_email_office","office@icarbonx.com",{"collectionId":52,"collectionName":53,"id":188,"key":189,"rich":56,"rich_en":56,"value":190,"value_en":190},"43v7tx4p8jg5781","contact_email_bd","bd@icarbonx.com",{"collectionId":52,"collectionName":53,"id":192,"key":193,"rich":56,"rich_en":56,"value":194,"value_en":194},"w98vw7sppu33z51","contact_email_hr","hr@icarbonx.com",{"collectionId":52,"collectionName":53,"id":196,"key":197,"rich":56,"rich_en":56,"value":198,"value_en":199},"n31tu2jmn66z48o","contact_label_email","电子邮箱：","Email:",[201,204,206,210,212,216],{"collectionId":6,"collectionName":7,"id":202,"label":9,"label_en":10,"position":203,"sort":12,"to":13},"89zd5122404ke2i","footer",{"collectionId":6,"collectionName":7,"id":205,"label":34,"label_en":35,"position":203,"sort":18,"to":37},"8n89f7o0s1t321p",{"collectionId":6,"collectionName":7,"id":207,"label":208,"label_en":209,"position":203,"sort":24,"to":19},"7573jk0xg279qc6","技术与平台","Technology & Platforms",{"collectionId":6,"collectionName":7,"id":211,"label":40,"label_en":41,"position":203,"sort":30,"to":43},"e4q2e4q39xb76mx",{"collectionId":6,"collectionName":7,"id":213,"label":214,"label_en":215,"position":203,"sort":36,"to":31},"tdotlb5tn821i16","产品与解决方案","Products & Solutions",{"collectionId":6,"collectionName":7,"id":217,"label":46,"label_en":47,"position":203,"sort":42,"to":49},"03wra0k3z082q32",{"category":219,"collectionId":220,"collectionName":221,"content":222,"content_en":223,"cover":224,"id":225,"published":226,"published_at":227,"slug":228,"summary":229,"summary_en":230,"title":231,"title_en":232,"views":233},"company","pbc_4287850865","articles","\u003Cp>近日，碳云智药与翰宇药业合作开发的创新药HY3003注射液获得美国食品药品监督管理局（FDA）临床试验许可。HY3003是一款GLP-1R\u002FGIPR\u002FGCGR三重受体激动剂，研究性新药申请（IND）编号为184763。FDA已完成安全性审查，允许按照研究方案开展首次人体临床试验。\u003C\u002Fp>\n\u003Ch2>从受理到获准开展临床试验\u003C\u002Fh2>\n\u003Cp>翰宇药业此前披露，FDA于2026年10月5日受理HY3003的IND申请。该申请在30天审查期内获准推进，期间未收到信息补充请求（Information Request，IR）。\u003C\u002Fp>\n\u003Cp>拟开展的HY3003-001研究为一项单中心、随机、双盲、安慰剂对照、单次剂量递增的健康成人临床试验，旨在评估HY3003的安全性、耐受性、药代动力学、药效学及免疫原性。HY3003采用每周一次皮下注射给药的制剂形式，拟探索的适应症包括体重管理、2型糖尿病及代谢功能障碍相关脂肪性肝炎（MASH）。\u003C\u002Fp>\n\u003Cp>\u003Cimg src=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=960\" alt=\"HY3003注射液产品示意图\" width=\"800\" height=\"533\" loading=\"lazy\" decoding=\"async\" srcset=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=320 320w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=640 640w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=960 960w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg 1080w\" sizes=\"(max-width: 767px) calc(100vw - 40px), 880px\" data-original-src=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg\" role=\"button\" tabindex=\"0\" aria-label=\"查看原图 \u002F View original image\">\u003C\u002Fp>\n\u003Ch2>合作研发与技术平台\u003C\u002Fh2>\n\u003Cp>在合作分工中，碳云智药运用“硅基多肽芯片×人工智能辅助药物设计（AIDD）”平台开展前端发现与筛选；翰宇药业负责临床前研究、IND申报及临床开发。双方于2024年10月建立战略合作，并于2025年5月就三靶点激动剂多肽药物签署联合开发协议。\u003C\u002Fp>\n\u003Cp>此次美国临床试验许可是HY3003研发进程中的一个阶段性节点。后续研究将按获准方案开展，以获取人体安全性及药理学数据。碳云智药将继续围绕多肽创新药研发推进合作。\u003C\u002Fp>\n\u003Cp>商务合作：\u003Ca href=\"mailto:bd@icarbonx.com\">bd@icarbonx.com\u003C\u002Fa>\u003C\u002Fp>","\u003Cp>HY3003 injection, an investigational drug co-developed by iCarbonX Pharmaceutical and Hybio Pharmaceutical, has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a clinical trial. HY3003 is a GLP-1R\u002FGIPR\u002FGCGR triple receptor agonist. The investigational new drug (IND) application is numbered 184763. Following completion of its safety review, the FDA has allowed the first-in-human study to proceed under the submitted protocol.\u003C\u002Fp>\n\u003Ch2>From IND Acceptance to Clinical Trial Clearance\u003C\u002Fh2>\n\u003Cp>Hybio Pharmaceutical previously disclosed that the FDA accepted the HY3003 IND on October 5, 2026. The application was cleared within the 30-day review period without an information request (IR).\u003C\u002Fp>\n\u003Cp>HY3003-001 is planned as a single-center, randomized, double-blind, placebo-controlled, single ascending dose study in healthy adults. It will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity. HY3003 is formulated for once-weekly subcutaneous injection. Its proposed indications include weight management, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH).\u003C\u002Fp>\n\u003Cp>\u003Cimg src=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=960\" alt=\"HY3003 injection product image\" width=\"800\" height=\"533\" loading=\"lazy\" decoding=\"async\" srcset=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=320 320w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=640 640w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg?w=960 960w, \u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg 1080w\" sizes=\"(max-width: 767px) calc(100vw - 40px), 880px\" data-original-src=\"\u002Fmedia\u002Finline\u002F1e1f8c4db7dc103600af445027980e71749d3fcf9f741f7951f3ba6201eef3e6.jpg\" role=\"button\" tabindex=\"0\" aria-label=\"查看原图 \u002F View original image\">\u003C\u002Fp>\n\u003Ch2>Joint Development and Technology Platform\u003C\u002Fh2>\n\u003Cp>iCarbonX Pharmaceutical applies its silicon-based peptide chip and AI-driven drug discovery (AIDD) platform to early discovery and screening. Hybio Pharmaceutical leads preclinical studies, IND filing, and clinical development. The two companies formed a strategic partnership in October 2024 and signed a joint development agreement for the triple agonist peptide candidate in May 2025.\u003C\u002Fp>\n\u003Cp>U.S. clinical trial clearance is a milestone in HY3003's development. The study will proceed under the cleared protocol to generate human safety and pharmacology data. iCarbonX Pharmaceutical will continue to advance collaborations in innovative peptide drug discovery.\u003C\u002Fp>\n\u003Cp>Business inquiries: \u003Ca href=\"mailto:bd@icarbonx.com\">bd@icarbonx.com\u003C\u002Fa>\u003C\u002Fp>","cover_textless_2c5yrc9y6m.png","2nwz9crm5ev554p",true,"2026-11-05 11:44:00.000Z","hy3003-us-fda-clinical-trial-clearance","碳云智药与翰宇药业合作开发的GLP-1R\u002FGIPR\u002FGCGR三重受体激动剂HY3003注射液获得美国FDA临床试验许可，将按方案开展首次人体临床试验。","The U.S. FDA has cleared the IND for HY3003, a GLP-1R\u002FGIPR\u002FGCGR triple receptor agonist injection co-developed by iCarbonX Pharmaceutical and Hybio Pharmaceutical, allowing its first-in-human trial to proceed under the protocol.","碳云智药合作创新药HY3003获美国FDA临床试验许可","HY3003, Co-developed by iCarbonX Pharmaceutical, Cleared for U.S. Clinical Trial",0,[235,245,253,261,269,277],{"category":236,"collectionId":220,"cover":237,"id":238,"published_at":239,"slug":240,"summary":241,"summary_en":242,"title":243,"title_en":244},"industry","cover_textless_9nfd7yv9pp.png","yc0xbhdi21hsd37","2026-11-02 12:00:00.000Z","why-multiplex-autoantibody-testing-matters","从自身免疫病流行病学、常见症状、自身抗体的临床意义及检测局限出发，介绍自身抗体联检在疾病早期识别、鉴别诊断及全病程管理中的价值，并探讨多指标联合检测的应用前景。","Autoantibodies are characteristic laboratory markers of autoimmune diseases. This article explores their clinical value and testing limitations, and why multiplex testing can support early identification, differential diagnosis and long-term disease management.","碳谈自免｜自身抗体联检的必要性","iCarbonX Autoimmunity Insights | Why Multiplex Autoantibody Testing Matters",{"category":236,"collectionId":220,"cover":246,"id":247,"published_at":248,"slug":56,"summary":249,"summary_en":250,"title":251,"title_en":252},"40hu0mjfq8_oundudd4ob.png","7819b5ci09100g5","2026-10-16 12:00:00.000Z","从过敏性疾病的发生机制、自然历程、过敏原类型和诊断方法入手，系统解读过敏原特异性IgE检测结果，并探讨高通量联检技术在过敏诊断领域的发展前景。","Explore allergic disease mechanisms, diagnostic approaches, and the interpretation of allergen-specific IgE results, with insights into multiplex testing and the future of precision allergy diagnostics.","碳谈过敏｜读懂过敏原检测报告","iCarbonX Allergy Insights | Understanding Allergen Test Reports",{"category":236,"collectionId":220,"cover":254,"id":255,"published_at":256,"slug":56,"summary":257,"summary_en":258,"title":259,"title_en":260},"6922f566_ad9f_43ca_8dec_46b5007990fa_isgiyeqp69.png","g4w6cld9yh5h409","2026-09-24 12:00:00.000Z","美国FDA专家委员会就GRAIL旗下多癌早筛产品Galleri的上市前批准申请给出支持性建议，推动多癌早筛迈向新的监管阶段。碳云智能依托硅基原位合成生物芯片、高通量检测与AI多组学分析技术，探索从基因变异、DNA甲基化到蛋白及免疫反应的多维度分子检测，为疾病早期识别和规模化健康筛查提供技术支持。","An FDA advisory committee has issued a favorable recommendation for GRAIL's Galleri multi-cancer early detection test, marking a significant regulatory milestone. iCarbonX is advancing silicon-based biochips, high-throughput molecular detection, and AI-driven multi-omics analysis to explore new possibilities in early disease detection and population-scale health screening.","多癌早筛迎来关键监管节点，硅基芯片如何看见更早的癌症信号？","Multi-Cancer Early Detection Reaches a Key Regulatory Milestone: How Can Silicon-Based Biochips Detect Earlier Cancer Signals?",{"category":219,"collectionId":220,"cover":262,"id":263,"published_at":264,"slug":56,"summary":265,"summary_en":266,"title":267,"title_en":268},"chat_gpt_image_2026_9_10_18_29_26_6w2zqvf0fu.png","h36z454dc4s08at","2026-09-10 12:00:00.000Z","HY3003注射液临床试验申请获受理。该药物由碳云智肽与翰宇药业合作开发，其核心候选分子源自碳云智肽“硅基多肽芯片 × AIDD”新药设计平台，标志着平台能力进一步进入真实药物管线与临床开发阶段。","HY3003 Injection, a GLP-1R\u002FGIPR\u002FGCGR triple receptor agonist jointly developed by iCarbonX Peptide and Hybio Pharmaceutical, has had its clinical trial application accepted for review by China’s National Medical Products Administration. The core candidate molecule was discovered through iCarbonX Peptide’s Silicon-based Peptide Chip × AIDD drug-design platform, marking a further step from platform-based molecular discovery toward clinical drug development.","三靶点减重创新药HY3003获受理，碳云智肽推动创新药从筛选走向设计","HY3003 Triple-Target Weight-Loss Drug Accepted for Review, Marking a Milestone for iCarbonX Peptide’s Silicon-Based Peptide Chip × AIDD Platform",{"category":236,"collectionId":220,"cover":270,"id":271,"published_at":272,"slug":56,"summary":273,"summary_en":274,"title":275,"title_en":276},"640_ez3o40p6hc.png","d6if2qm32k33yx4","2026-08-29 12:00:00.000Z","近日，国家医保局正式印发《检验类医疗服务价格项目立项指南（试行）》，为全国检验类收费定下了统一的\"标尺\"。这一里程碑式的政策，正深刻重塑体外诊断（IVD）产业的格局，也为以硅基原位合成生物芯片为核心技术平台的碳云智能，带来了前所未有的战略机遇。","Recently, China’s National Healthcare Security Administration (NHSA) officially issued the Guidelines for Establishing Medical Service Price Items for Laboratory Testing (Trial), introducing a unified framework for laboratory service pricing nationwide.","重磅！国家医保局《检验类立项指南》发布，碳云硅基芯片技术迎来 IVD 产业新机遇","China’s NHSA Releases New Guidelines for Laboratory Service Pricing, Opening New Opportunities for iCarbonX’s Silicon-Based Biochip Technology",{"category":278,"collectionId":220,"cover":279,"id":280,"published_at":281,"slug":56,"summary":282,"summary_en":283,"title":284,"title_en":285},"research","chat_gpt_image_2026_8_20_17_38_03_oeqlsarwf8.png","kwr2x401q8jboot","2026-08-20 12:00:00.000Z","Moderna与默沙东联合开发的个体化mRNA癌症疫苗intismeran autogene（V940\u002FmRNA-4157）联合Keytruda在高危黑色素瘤III期INTerpath-001研究中达到主要终点和关键次要终点。文章聚焦个体化新抗原治疗上游的精准检测能力，并介绍碳云智能以ctDNA检测、iCVariaX™碳云芯因™芯片、TCR硅基多肽芯片及AIDD技术构建“突变检测—新抗原鉴定—个性化新药设计”闭环的探索。","Moderna and Merck announced that intismeran autogene (V940\u002FmRNA-4157), their individualized mRNA cancer vaccine, met the primary and key secondary endpoints in the phase 3 INTerpath-001 trial with Keytruda in high-risk melanoma. The article examines why precision testing is foundational to personalized neoantigen therapy and outlines iCarbonX’s work across ctDNA mutation detection, iCVariaX™ Gene Chip analysis, TCR silicon-based peptide chips and AI-driven drug discovery.","癌症疫苗III期突破：真正决定“一人一药”能走多远的，是精准检测","Phase 3 Cancer-Vaccine Breakthrough: Precision Testing Will Determine How Far One-Patient, One-Therapy Can Go"]